Alpine Immune Sciences, Inc.

CIK 1626199 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alpine Immune Sciences, Inc..

Recent SEC filings

FiledFormAccession number
Nov 14, 2024SC 13G/A0001172661-24-005283
May 30, 202415-12G0001193125-24-149921
May 23, 2024EFFECT9999999995-24-001631
May 23, 2024EFFECT9999999995-24-001632
May 21, 2024SC 13D/A0001104659-24-063883
May 21, 2024SC 13D/A0001193125-24-143527
May 20, 2024S-8 POS0001193125-24-142301
May 20, 2024S-8 POS0001193125-24-142298
May 20, 202440001626199-24-000098
May 20, 2024SC 14D9/A0001193125-24-142270
May 20, 2024S-8 POS0001193125-24-142310
May 20, 2024S-8 POS0001193125-24-142308
May 20, 202440001626199-24-000100
May 20, 2024POS AM0001193125-24-142291
May 20, 2024SC TO-T/A0001193125-24-142268
May 20, 2024POS AM0001193125-24-142292
May 20, 202440001626199-24-000092
May 20, 202440000947871-24-000504
May 20, 2024S-8 POS0001193125-24-142305
May 20, 202440001626199-24-000090
May 20, 202425-NSE0001354457-24-000354
May 20, 2024S-8 POS0001193125-24-142311
May 20, 2024S-8 POS0001193125-24-142306
May 20, 2024S-8 POS0001193125-24-142314
May 20, 2024S-8 POS0001193125-24-142315